---
title: "Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279778511.md"
description: "Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results"
datetime: "2026-03-19T11:38:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279778511.md)
  - [en](https://longbridge.com/en/news/279778511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279778511.md)
---

# Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results

Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results

### Related Stocks

- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [02500.HK](https://longbridge.com/en/quote/02500.HK.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)

## Related News & Research

- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [CK Life Sciences shareholders pass AGM resolutions on director elections, mandates](https://longbridge.com/en/news/287189492.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [SSY Group wins China NMPA approval for emedastine difumarate eye drops 0.05%](https://longbridge.com/en/news/287187916.md)
- [Shanghai Henlius says China regulator clears HLX48 Phase 1 trial IND for solid tumors](https://longbridge.com/en/news/287189347.md)